Officials unleash sterile mosquitoes in bid to curb disease — with promising results
A battle is underway against an invasive mosquito behind a recent surge in the local spread of dengue fever in Southern California — and officials may have unlocked a powerful tool to help win the day.
Two vector control districts — local agencies tasked with controlling disease-spreading organisms — released thousands of sterile male mosquitoes in select neighborhoods, with one district starting in 2023 and the other beginning the following year.
The idea was to drive down the mosquito population because eggs produced by a female after a romp with a sterile male don't hatch. And only female mosquitoes bite, so unleashing males doesn't lead to transmission of diseases such as dengue, a potentially fatal viral infection.
The data so far are encouraging.
One agency serving a large swath of Los Angeles County found a nearly 82% reduction in its invasive Aedes aegypti mosquito population in its release area in Sunland-Tujunga last year compared with a control area.
Another district, covering the southwestern corner of San Bernardino County, logged an average decrease of 44% across several heavily infested places where it unleashed the sterile males last year, compared with pre-intervention levels.
Overall invasive mosquito counts dropped 33% across the district — marking the first time in roughly eight years that the population went down instead of up.
'Not only were we out in the field and actually seeing good reductions, but we were getting a lot less calls — people calling in to complain,' said Brian Reisinger, community outreach coordinator for the Inland Empire's West Valley Mosquito and Vector Control District.
But challenges remain. Scaling the intervention to the level needed to make a dent in the vast region served by the L.A. County district won't happen overnight and would potentially require its home owners to pay up to $20 in an annual charge on their property tax bill to make it happen.
Climate change is allowing Aedes mosquitoes — and diseases they spread — to move into new areas and go gangbusters in places where they're established.
Surging dengue abroad and the widespread presence of Aedes mosquitoes at home is 'creating this perfect recipe for local transmission in our region,' said Dr. Aiman Halai, director of the vector-borne disease unit at the L.A. County Department of Public Health.
Aedes aegypti mosquitoes were first detected in California about a decade ago. Originally hailing from Africa, the species can transmit dengue, as well as yellow fever, Zika and chikungunya.
Another invasive mosquito, Aedes albopictus, arrived earlier, but its numbers have declined and it is less likely to spread diseases such as dengue.
Although the black-and-white striped Aedes aegypti can't fly far — just about 150 to 200 yards — they manage to get around. The low-flying, day-biting mosquitoes are present in more than a third of California's counties, including Shasta County in the far north. An Aedes mosquito, known for nipping ankles, prefers to bite humans over animals. The insects, which arrived in California about a decade ago, can transmit diseases such as dengue and Zika.
Aedes mosquitoes love to bite people — often multiple times in rapid succession. As the insects spread across the state, patios and backyards morphed from respites into risky territories.
But tamping down the bugs has proved difficult. They can lay their eggs in tiny water sources. And they might lay a few in a plant tray and others, perhaps, in a drain. Annihilating invaders isn't easy when it can be hard to locate all the reproduction spots — or access all the yards where breeding is rampant.
That's one of the reasons why releasing sterilized males is attractive: They're naturally adept at finding their own kind.
Releasing sterilized male insects to combat pests is a proven scientific technique that's been around since the 1950s, but using it to control invasive mosquitoes is relatively new. The approach appears to be catching on in Southern California.
The West Valley district pioneered the release of sterilized male mosquitoes in California. In 2023, the Ontario-based agency rolled out a pilot program before expanding it the following year. This year it is increasing the number of sites being treated.
The Greater Los Angeles County Vector Control District launched its own pilot effort in 2024 and plans to target roughly the same area this year — with some improvements in technique and insect-rearing capacity.
Starting in late May, an Orange County district will follow suit with the planned release of 100,000 to 200,000 sterile male mosquitoes a week in Mission Viejo through November. A Coachella Valley district is plugging away at developing its own program, which could get off the ground next spring.
Vector officials in L.A. and San Bernardino counties said residents are asking them when they can bring a batch of zapped males to their neighborhood. But experts say for large population centers, it's not that easy.
'I just responded this morning to one of our residents that says, 'Why can't we have this everywhere this year?' And it's, of course, because Rome wasn't built in a day,' said Susanne Kluh, general manager for the Greater Los Angeles County Vector Control District.
Kluh's district has a budget of nearly $24 million and is responsible for nearly 6 million residents across 36 cities and unincorporated areas. West Valley's budget this fiscal year is roughly $4 million, and the district serves roughly 650,000 people in six cities and surrounding county areas.
Approaches between the two districts differ, in part due to the scale they're working with.
West Valley targets what it calls hot spots — areas with particularly high mosquito counts. Last year, before peak mosquito season, it released about 1,000 sterile males biweekly per site. Then the district bumped it to up to 3,000 for certain sites for the peak period, which runs from August to November. The idea is to outnumber wild males by 100 to 1. Equipment for the program cost about $200,000 and the district hired a full-time staffer to assist with the efforts this year for $65,000.
Solomon Birhanie, scientific director for West Valley, said the district doesn't have the resources to attack large tracts of land so it's using the resources it does have efficiently. Focusing on problem sites has shown to be sufficient to affect the whole service area, he said.
'Many medium to smaller districts are now interested to use our approach,' he said, because there's now evidence that it can be incorporated into abatement programs 'without the need for hiring highly skilled personnel or demanding a larger amount of budget.' Solomon Birhanie, scientific director at the West Valley Mosquito and Vector Control District, views a container of mosquito larvae in the lab in March 2024. The Ontario-based district pioneered the release of sterilized male Aedes mosquitoes in California.
In its inaugural study last year, the L.A. County district unleashed an average of 30,000 males per week in two Sunland-Tujunga neighborhoods between May and October — seeking to outperform wild males 10 to 1. Kluh anticipates this year's pilot will cost about $350,000.
In order to bring the program to a larger area of the district, Kluh said more funding is needed — with officials proposing up to $20 annually per single-family home. That would be in addition to the $18.97 district homeowners now pay for the services the agency already provides.
If surveys sent to a sample of property owners favor the new charge, it'll go to a vote in the fall, as required by Proposition 218, Kluh said.
There are five vector control districts that cover L.A. County. The Greater L.A. County district is the largest, stretching from San Pedro to Santa Clarita. It covers most of L.A. city except for coastal regions and doesn't serve the San Gabriel or Antelope valleys.
California last year had 18 locally acquired dengue cases, meaning people were infected with the viral disease in their communities, not while traveling.
Fourteen of those cases were in Los Angeles County, including at least seven tied to a small outbreak in Baldwin Park, a city east of L.A. Cases also cropped up in Panorama City, El Monte and the Hollywood Hills.
The year before that, the state confirmed its first locally acquired cases, in Long Beach and Pasadena.
Although most people with dengue have no symptoms, it can cause severe body aches and fever and, in rare cases, death. Its alias, 'breakbone fever,' provides a grim glimpse into what it can feel like.
Over a third of L.A. County's dengue cases last year required hospitalization, according to Halai.
Mosquitoes pick up the virus after they bite an infected person, then spread it by biting others.
Mosquito control experts tout sterilization for being environmentally friendly because it doesn't involve spraying chemicals and officials could potentially use it to target other disease spreaders — such as the region's native Culex mosquito, a carrier of the deadly West Nile virus.
New technologies continue to come online. In the summer last year, the California Department of Pesticide Regulation approved the use of male mosquitoes infected with a particular strain of a bacteria called Wolbachia. Eggs fertilized by those males also don't hatch.
Despite the promising innovations, some aspects of the scourge defy local control.
Since her start in mosquito control in California nearly 26 years ago, Kluh said, the season for the insects has lengthened as winters have become shorter. Back then, officials would get to work in late April or early May and wrap up around early October. Now the native mosquitoes emerge as early as March and the invasive insects can stick around into December.
'If things are going the way it is going now, we could just always have some dengue circulating,' she said.
Last year marked the worst year on record for dengue globally, with more than 13 million cases reported in the Americas and the Caribbean, according to the Centers for Disease Control.
Many countries are still reporting higher-than-average dengue numbers, meaning there's more opportunity for travelers to bring it home.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
What Happens in Sierra Leone's Mpox Outbreak Affects Us All
Sentinel scientists collaborating to sequence mpox samples Credit - Kat Kendon—Kendon Photography A dangerous mpox outbreak is unfolding in Sierra Leone. In just the first week of May, cases rose by 61%, and suspected cases surged by 71%. Roughly half of all confirmed mpox cases in Africa now come from this small West African nation. The virus is moving widely, across geographies, genders, and age groups. And the virus is changing. Genomic analysis has revealed a fast-moving new variant of mpox—called G.1—that likely emerged in late November. At first it circulated silently but has since taken hold and quickly began sustained human-to-human transmission. Cases have been doubling every two weeks. Estimates suggest more than 11,000 people in Sierra Leone may already be infected. This is how outbreaks become epidemics, and mpox, as a pandemic, could be brutal. Mpox (formerly known as monkeypox) belongs to the same viral family as smallpox. It causes a disease that can be painful, disfiguring, and debilitating, particularly in children. In Sierra Leone, nearly all patients present with severe rashes, and about a quarter have required hospitalization; in some, the disease has progressed to necrotizing lesions. It's no longer rare, no longer contained to the LGBTQ community, and it has already reached more than 100 countries. Read More: Tedros Adhanom Ghebreyesus: Global-health architect Sierra Leone has been here before, at the epicenter of a disease outbreak while the world looked away. In 2014, Ebola swept through the West African region. A single mutation supercharged its spread just as it reached Sierra Leone. Tens of thousands died. Health systems collapsed. The global cost soared into the billions. The lesson? Delay is deadly. As infectious disease researchers, we've lived that lesson. For two decades, we've worked alongside colleagues across Africa and around the world to build faster, smarter ways to detect and respond to outbreaks. We were on the ground during Ebola, Zika, the COVID-19 pandemic, and recently Marburg—plus, many outbreaks that never made the news because they were stopped in time. Together, we've built technologies that track viruses in real time and trained thousands of frontline workers to use them. What once took months, we can now do in days. And now, in Sierra Leone, we are putting that progress to the test. This time, Sierra Leone isn't waiting for others to step in to do testing and sequencing—it's leading. Within days of the outbreak's escalation, local public-health teams and scientists under the leadership of Sierra Leone's National Public Health Agency—working with international partners including ourselves—expanded testing, began sequencing the virus, analyzed its evolution, and shared data in real-time. They also launched robust social mobilization and contact tracing that are helping to slow the spread. To stay ahead of the virus, teams in Sierra Leone are using powerful new tools. One is Lookout, our real-time national platform that fuses genomic, diagnostic, clinical, and epidemiological data into a single cloud-based system. As more data come in, Lookout gives health officials a live, evolving map of the outbreak, showing where it's spreading, how it's changing, and where to act next. Lookout is just one example of the infrastructure that teams in the U.S. and Africa have co-created through decades of collaboration. It belongs to a broader system called Sentinel, an outbreak detection and response network we co-lead, launched with support from the Audacious Project, a collaborative funding initiative housed at TED. Sentinel is just one part of a larger movement: scientists, engineers, public health leaders, industry partners, and frontline workers working together to build faster, smarter systems to stop outbreaks before they explode. But even the best systems can't run without support. Earlier this year, the U.S. canceled all funding to Sierra Leone and halted a $120 million initiative by the U.S. Centers for Disease Control and Prevention (CDC) aimed at strengthening epidemic preparedness in the country. The Africa CDC, U.S. CDC, World Health Organization (WHO) and other organizations continue to offer vital support, but with far fewer resources than before. Philanthropic and industry partners, including the ELMA Relief Foundation, Danaher, and Illumina, have admirably stepped in, but they cannot fill the gap alone. Today, local teams are doing so much right—with nearly everything stacked against them. The warning signs are flashing. But their resources are running out. Read More: 'This is About Children's Lives': Gavi's CEO Makes the Case for Funding the Global Vaccine Alliance It's tempting to believe this isn't our problem. But thanks to collaborative sequencing efforts, we know the G.1 variant spreading in Sierra Leone has already been detected in at least five patients across multiple U.S. states—Massachusetts, Illinois, and California—and in Europe. It may seem distant—like COVID-19 did at first—but it's not. Yes, vaccines exist, and they are expected to be effective against this new variant. But supply is limited, distribution is deeply inequitable, and the vaccines themselves present challenges—from limited clinical data and uncertain duration of protection to storage requirements—that make large-scale campaigns far from straightforward. West Africa has received only a fraction of the doses it needs. Without both vaccine access and real-time tracking, we're flying blind. Surveillance isn't a luxury. It's our first and best line of defense. Sierra Leone is showing the world what preparedness looks like. But it shouldn't have to stand alone. We can wait—again—until the virus spreads further. Or we can act now, support the leaders in Sierra Leone already responding, and get them the resources they need—like diagnostics, clinical support, vaccines, sequencing reagents, and frontline outbreak response—to save lives and cut this outbreak short. We've seen how the story of viral outbreaks can unfold. This time, with the present mpox epidemic in Sierra Leone, we still have a chance to change the ending. Disclosure: TIME's owners and co-chairs Marc and Lynne Benioff are philanthropic supporters of Sentinel. Contact us at letters@
Time Magazine
10 hours ago
- Time Magazine
Sierra Leone Is Battling an Mpox Outbreak. What Happens Next Affects Us All
A dangerous mpox outbreak is unfolding in Sierra Leone. In just the first week of May, cases rose by 61%, and suspected cases surged by 71%. Roughly half of all confirmed mpox cases in Africa now come from this small West African nation. The virus is moving widely, across geographies, genders, and age groups. And the virus is changing. Genomic analysis has revealed a fast-moving new variant of mpox—called G.1—that likely emerged in late November. At first it circulated silently but has since taken hold and quickly began sustained human-to-human transmission. Cases have been doubling every two weeks. Estimates suggest more than 11,000 people in Sierra Leone may already be infected. This is how outbreaks become epidemics, and mpox, as a pandemic, could be brutal. Mpox (formerly known as monkeypox) belongs to the same viral family as smallpox. It causes a disease that can be painful, disfiguring, and debilitating, particularly in children. In Sierra Leone, nearly all patients present with severe rashes, and about a quarter have required hospitalization; in some, the disease has progressed to necrotizing lesions. It's no longer rare, no longer contained to the LGBTQ community, and it has already reached more than 100 countries. Read More: Tedros Adhanom Ghebreyesus: Global-health architect Sierra Leone has been here before, at the epicenter of a disease outbreak while the world looked away. In 2014, Ebola swept through the West African region. A single mutation supercharged its spread just as it reached Sierra Leone. Tens of thousands died. Health systems collapsed. The global cost soared into the billions. The lesson? Delay is deadly. As infectious disease researchers, we've lived that lesson. For two decades, we've worked alongside colleagues across Africa and around the world to build faster, smarter ways to detect and respond to outbreaks. We were on the ground during Ebola, Zika, the COVID-19 pandemic, and recently Marburg—plus, many outbreaks that never made the news because they were stopped in time. Together, we've built technologies that track viruses in real time and trained thousands of frontline workers to use them. What once took months, we can now do in days. And now, in Sierra Leone, we are putting that progress to the test. This time, Sierra Leone isn't waiting for others to step in to do testing and sequencing—it's leading. Within days of the outbreak's escalation, local public-health teams and scientists under the leadership of Sierra Leone's National Public Health Agency—working with international partners including ourselves—expanded testing, began sequencing the virus, analyzed its evolution, and shared data in real-time. They also launched robust social mobilization and contact tracing that are helping to slow the spread. To stay ahead of the virus, teams in Sierra Leone are using powerful new tools. One is Lookout, our real-time national platform that fuses genomic, diagnostic, clinical, and epidemiological data into a single cloud-based system. As more data come in, Lookout gives health officials a live, evolving map of the outbreak, showing where it's spreading, how it's changing, and where to act next. Lookout is just one example of the infrastructure that teams in the U.S. and Africa have co-created through decades of collaboration. It belongs to a broader system called Sentinel, an outbreak detection and response network we co-lead, launched with support from the Audacious Project, a collaborative funding initiative housed at TED. Sentinel is just one part of a larger movement: scientists, engineers, public health leaders, industry partners, and frontline workers working together to build faster, smarter systems to stop outbreaks before they explode. But even the best systems can't run without support. Earlier this year, the U.S. canceled all funding to Sierra Leone and halted a $120 million initiative by the U.S. Centers for Disease Control and Prevention (CDC) aimed at strengthening epidemic preparedness in the country. The Africa CDC, U.S. CDC, World Health Organization (WHO) and other organizations continue to offer vital support, but with far fewer resources than before. Philanthropic and industry partners, including the ELMA Relief Foundation, Danaher, and Illumina, have admirably stepped in, but they cannot fill the gap alone. Today, local teams are doing so much right—with nearly everything stacked against them. The warning signs are flashing. But their resources are running out. It's tempting to believe this isn't our problem. But thanks to collaborative sequencing efforts, we know the G.1 variant spreading in Sierra Leone has already been detected in at least five patients across multiple U.S. states—Massachusetts, Illinois, and California—and in Europe. It may seem distant—like COVID-19 did at first—but it's not. Yes, vaccines exist, and they are expected to be effective against this new variant. But supply is limited, distribution is deeply inequitable, and the vaccines themselves present challenges—from limited clinical data and uncertain duration of protection to storage requirements—that make large-scale campaigns far from straightforward. West Africa has received only a fraction of the doses it needs. Without both vaccine access and real-time tracking, we're flying blind. Surveillance isn't a luxury. It's our first and best line of defense. Sierra Leone is showing the world what preparedness looks like. But it shouldn't have to stand alone. We can wait—again—until the virus spreads further. Or we can act now, support the leaders in Sierra Leone already responding, and get them the resources they need—like diagnostics, clinical support, vaccines, sequencing reagents, and frontline outbreak response—to save lives and cut this outbreak short. We've seen how the story of viral outbreaks can unfold. This time, with the present mpox epidemic in Sierra Leone, we still have a chance to change the ending.
Medscape
10 hours ago
- Medscape
Europe Launches New Climate Change and Health Commission
The World Health Organization (WHO) has launched a new European commission aimed at providing health sector solutions to what it called one of the defining health challenges of our time: climate change. The Pan-European Commission on Climate and Health (PECCH) is an independent advisory group convened by WHO Europe that brings together 11 commissioners from across the region, with Sir Andrew Haines of the London School of Hygiene & Tropical Medicine as the chief scientific advisor. The commission will deliver recommendations that address the intersection of health and climate. At a press briefing today in Reykjavík, Iceland, PECCH chair, former Icelandic Prime Minister Her Excellency Katrín Jakobsdóttir said that although climate change has been a big issue in global politics for decades, not enough has been done. 'We've seen too many reports and not enough action,' she said. 'I know it's difficult to implement policy on climate change, [but] we will be focused on what actually can be done. I'm optimistic that we will deliver concrete recommendations.' At the Epicenter of Climate Change Europe is the fastest warming continent in the world, with 2024 the warmest year on record, according to the European Environment Agency. Extreme weather events have caused up to 145,000 deaths across Europe in the past 40 years, with a majority caused by heatwaves. The changing climate also continues to alter the distribution of disease vectors, with the expansion of dengue, chikungunya, and Zika viruses, and to impact food systems, water quality, and ecosystems. Despite the growing threat posed by climate change, action — including within the health sector — remains inadequate to match the level of response required. PECCH will attempt to address the health impacts of climate change by determining interconnected health risks and opportunities for health improvement through adaptation and mitigation strategies, identifying gaps in government actions and policies, recommending strategies for action, increasing awareness on the role of health in climate policy, and advising the WHO. Will Words Translate to Actions? Professor of health systems research at Macquarie University, Sydney, Australia and founding director of the Australian Institute of Health Innovation, Jeffrey Braithwaite, PhD, told Medscape Medical News he believed the new commission holds a lot of promise. Jeffrey Braithwaite, PhD 'It seems designed to help raise more awareness, with some jurisdictions, companies and institutions flagging a bit under the weight of disinformation,' said Braithwaite, who is past president of the International Society for Quality in Health Care. 'The US, under the current White House, is of course hostile to the climate change agenda, so a lot of heavy political lifting and keeping the agenda for change going will fall to Europe.' Professor of population and planetary health at the University of Notre Dame, Sydney, Australia, Lynne Madden, MBBS, MPH, MSc, said addressing climate change and health requires a systems approach to a very complex problem. Lynne Madden, MBBS, MPH, MSc 'It appears that the commission is planning to take a systems approach and look at the interconnected global and regional risks to health to form recommendations to achieve a health net zero emission future. This is encouraging,' she told Medscape Medical News . 'Europe is probably the region most likely to make a commission like this work. What we don't need is more meetings that produce informed statements but very little real action that tackles climate change and its health effects. The big question is: Beyond the rhetoric, will the commission be able to do anything now that hasn't been done before to make national governments take meaningful action to halt climate change?' She added that it was critical to increase the climate resilience of healthcare systems, commit to delivering net zero healthcare and preferably zero carbon healthcare, develop the climate health capacity of healthcare workforces, and ensure the education of health professionals on the health impacts of climate change and give them the competency to take action, including eliminating the delivery of unnecessary healthcare. Healthcare's Huge Carbon Footprint Others agreed it was time for the health sector to step up and to take accountability and action for its own carbon footprint, with the sector contributing roughly 5% of global emissions — more than all commercial air travel. Kayvan Shokrollahi, MBBS, MSc, LLM 'Healthcare has a major impact on the environment, and it is one area where we see simultaneous cost savings along with most sustainability interventions. I like this because there is less tension, and politics can align better with 'this will save money and help the environment' rather than 'this will cost money,'' Kayvan Shokrollahi, MBBS, MSc, LLM, consultant plastic and laser surgeon and honorary clinical professor at the University of Liverpool, United Kingdom, told Medscape Medical News . He recently conducted a carbon footprint study of his burn center to identify aspects of burn care that contribute most to the carbon footprint and wastage and to explore interventions to help reduce waste. He and his colleagues found that hospitals and surgical clinics are the second largest waste contributors in the UK, generating more than 6600 tons of waste per day. Current waste disposal practices such as incineration, landfilling, and sterilization post environmental threats. At the same time, up to 1 billion liters of water a year are wasted by running taps across the NHS pumping network to flush Pseudomonas and Legionella in the absence of other alternative solutions. 'Our research demonstrated a rough extrapolation of £2 million of savings from reduced plastic waste from one intervention whilst also saving 150 tons of CO 2 . Progress in healthcare sustainability is a case of implementing large numbers of simple cumulative interventions, not one big one.' Braithwaite cited his and his colleagues' recent systematic review on strategies and tactics that could be used to reduce the impact of healthcare on climate change, of which they developed a framework to support the decarbonization of healthcare systems. Such strategies included changing clinical and surgical practices, reducing physical waste, and enabling change through actions of individuals and groups. Looking forward, the PECCH will engage with representatives from other regions to work together on shared solutions. Its final recommendations for health and climate action will be presented during the World Health Assembly next May.
